FP
Therapeutic Areas
Aummune Pipeline
| Drug | Indication | Phase |
|---|---|---|
| AM003 | Solid Tumors | Phase 1 |
Leadership Team at Aummune
BL
Barry Labinger
CEO
DK
Dr. Karen Smith
Director & Interim CMO
MN
Marius Nacht
Founder & Investor
DM
Dr. Michael Shenhav
Director
DU
Dr. Uri Yaron
Director
BL
Barry Labinger
CEO
DK
Dr. Karen Smith
Director & Interim CMO
MN
Marius Nacht
Founder & Investor
DM
Dr. Michael Shenhav
Director
DU
Dr. Uri Yaron
Director